Bharat Parenterals Ltd.BSE: BPLPHARMA

Announcement under Regulation 30 (LODR)-Preferential Issue

· Issued by Bharat Parenterals Ltd. via BSE India

Filed with BSE · ISIN INE365Y01019 · · 12 pages · English

Summary by 6ix AI

Bharat Parenterals Ltd. has filed a disclosure regarding the approval of resolutions from their Extraordinary General Meeting held recently. The resolutions include the issuance of equity shares on a preferential basis and making investments beyond specified limits under the Companies Act. The filing includes voting results and a report from the Scrutinizer confirming the outcomes of the votes cast.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

This is to inform you that the resolutions mentioned (as stated below) in the Notice of the Extraordinary General Meeting (“EGM”) dated October 01, 2026 read with corrigendum dated October 13, 2026 (“EGM Notice”), has been approved by the shareholders with requisite majority at their EGM held today i.e. Friday, October 23, 2026. a) Issuance of equity shares of the Company on preferential basis, an

Bharat Parenterals Ltd. on 6ix

Story so far

Earlier from Bharat Parenterals

Later from Bharat Parenterals

All Bharat Parenterals news releases